X0306 4 2022-03-04 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001798443 Kalif Eliyahu Sharon C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 EVP, Chief Financial Officer Ordinary Shares 2022-03-05 4 M 0 21387 A 64876 D Restricted Share Units 2022-03-04 4 A 0 134048 0.00 A Ordinary Shares 134048 134048 D Restricted Share Units 2022-03-05 4 M 0 21387 0.00 D Ordinary Shares 21387 64164 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026. Restricted share units were granted on March 5, 2021, with 21,387 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and 21,390 vesting on March 5, 2025. /s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif 2022-03-08